BPC-157 vs KPV
A side-by-side research comparison of BPC-157 and KPV across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | BPC-157 | KPV |
|---|---|---|
| Full name | Body Protection Compound-157 | Lysine-Proline-Valine Tripeptide |
| Category | Healing & Recovery | Healing & Recovery |
| Status | Research compound | Research compound |
| Mechanism | Upregulates growth factor expression including VEGF and promotes angiogenesis, modulates nitric oxide system, and interacts with the dopaminergic system. | Inhibits NF-kB signaling pathway, reduces pro-inflammatory cytokine production (TNF-α, IL-6), and modulates immune cell activation. |
| Molecular weight | 1419.53 Da | 342.43 Da |
| Half-life | ~4 hours | ~2-3 hours |
| Bioavailability | Variable; oral and injectable forms available | ~60-70% oral; higher subcutaneous |
| Typical dose | 250-500 mcg per dose | 200-500 mcg per dose |
| Frequency | 1-2x daily | 1-2x daily |
| Route | Subcutaneous injection (or oral capsules) | Oral, topical, or subcutaneous |
BPC-157 reported benefits
- Accelerated tendon and ligament healing
- Gut lining protection and repair
- Neuroprotective effects
- Anti-inflammatory properties
- Muscle tear recovery
KPV reported benefits
- Potent anti-inflammatory
- Gut inflammation reduction
- Skin condition improvement
- Immune modulation
Related comparisons
Research and educational reference only. Not medical advice.